Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prospective Evaluation of AI-ECG for SHD Detection — Stella

Home/Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)/Prospective Evaluation of AI-ECG for SHD Detection

View on ClinicalTrials.gov

Recruiting

Back to Valvular Heart Disease Stenosis and Regurgitation (Diagnosis) trials

Prospective Evaluation of AI-ECG for SHD Detection

Trial locations(5 sites)

United Kingdom

Southmead Hospital, Bristol

Chelsea and Westminster Hospital, London

Hammersmith Hospital, London

St Mary's Hospital, London

West Middlesex University Hospital, London

Key details

Sponsor

Imperial College London

Enrollment target

~590 participants

Started

November 2025

Primary completion

May 2027

Age range

18 Years – 90 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.